Recent News - Cannabis


Lunch and Learn Series: New Employment Laws and Regulations Regarding Marijuana in the Workplace
October 20, 2022 | Health Services | Cannabis

Please join us for the November Lunch and Learn as Rivkin Radler Partners John Diviney and Tamika Hardy discuss the following topics:

  • New State laws – New York Marijuana Regulation and Taxation Act, New York Labor Law Section 201-D, New York Human Rights Law, New York Penal Law, New York City Administrative Code
  • Pre-employment
Read More
Share this article:
Rivkin Radler Attorneys Named 2022 New York Metro Super Lawyers®/Rising Stars
September 22, 2022

Rivkin Radler LLP is pleased to announce that 32 attorneys were named to the 2022 New York Metro Super Lawyers List and 14 attorneys were named 2022 New York Metro Rising Stars. Following is a list of attorneys and the practice areas for which they were recognized.

Being named a Super Lawyer is an honor

Read More
Share this article:
Ullman Reacts to FDA’s Amnesty for NDIN Non-Filers
June 10, 2022 | Compliance Investigations & White Collar

Marc Ullman spoke with Natural Products INSIDER for the article, “FDA hoping to shrink pool of noncompliant ingredient notifications.”

The story discusses the U.S. Food & Drug Administration’s recent guidance that it is providing a 180-day amnesty to manufacturers of nutritional products that failed to file a New Dietary Ingredient (NDI) notification.

Marc is not convinced

Read More
Share this article:
Ullman Weighs In on FDA Warnings and the Delta-8 THC Market
May 16, 2022 | Cannabis

Ullman was cited in the Natural Products Insider article “Lawyers skeptical FDA warning letters will chill delta-8 THC market.”

The article discusses the effect of the recent rash of FDA warning letters on delta-8 THC products. The warning letters note that delta-8 THC is not an approved treatment for medical conditions.

Asked whether the warning

Read More
Share this article:
Ullman Quoted in Article on FDA’s Enforcement Discretion for CBD
April 26, 2022 | Compliance Investigations & White Collar | Cannabis

Marc Ullman was quoted in the Natural Products Insider article, “FDA written enforcement discretion on CBD unlikely.”

The article discusses how the FDA is unlikely to issue a formal policy of enforcement discretion for CBD-containing products marketed as dietary supplements.

Ullman doesn’t believe the agency would issue a CBD enforcement discretion policy similar to NAC.

Read More
Share this article:
Vlahos Offers ‘Wish List’ for Gov. Hochul in Long Island Business News
August 30, 2021 | Corporate | Tax

In the Long Island Business News article, “To: Gov. Kathy Hochul, From: Long Island, Re: Wish list,” several Long Island business leaders offered their perspective on the issues New York’s newest governor should focus on first.

Louis Vlahos provided a business-friendly agenda:

  • Eliminate the stock transfer tax
  • Eliminate NYC’s commercial rent tax
  • Reduce the personal
Read More
Share this article:
Hardy Speaks at Panel on Marijuana Regulation and Taxation Act
July 22, 2021 | Employment & Labor | Cannabis

On July 21, 2021, Tamika Hardy spoke at the Employment & NY Marijuana Legalization (MRTA) panel, presented by the Brooklyn branch of the NAACP.

The Brooklyn NAACP’s Justice Reform and Legal Redress Committees discussed the New York legalization of cannabis as it relates to employment.

Hardy discussed what recreational cannabis legalization means in the employment

Read More
Share this article:
JD Supra Names Vlahos a Top Tax Author for 2021
April 8, 2021 | Tax

Rivkin Radler LLP is pleased to announce that Louis Vlahos placed No. 2 among the top 10 authors on the topic of tax law for 2021 in JD Supra’s Readers’ Choice Awards. Lou is a partner in the firm’s Business Dissolution; Cannabis; Corporate; Personal, Family & Business Planning; and Tax practice groups.

This year’s Readers’

Read More
Share this article:
Shapiro Quoted on CBD Warning Letters in Vitamin Retailer
March 29, 2021 | Compliance Investigations & White Collar | Cannabis

Steven Shapiro was quoted in the Vitamin Retailer article, “FDA Warns Selling of Topical CBD Products Violates FD&C Act.”

The FDA has issued warning letters to two companies addressing the illegal marketing of unapproved drugs labeled as containing CBD.

Shapiro questions the letters as neither discussed the potential to use CBD as an inactive ingredient

Read More
Share this article:
Ullman to Speak at Dietary Supplement (GMP) Compliance Virtual Seminar
March 9, 2021 | Health Services

Marc Ullman will be a speaker at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Virtual Seminar.

The event will be held on May 3, 5, 10 & 12, 2021.

In these unprecedented times, the dietary supplement industry is playing an essential role for the U.S. consumer. Never before have more questions been raised regarding

Read More
Share this article:
Next Page

Get legal updates and news delivered to your inbox